{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:02:04Z","timestamp":1792202524098,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09476-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T18:25:56Z","timestamp":1767810356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Organoid Modeling and Single-Cell Profiling Reveal Smooth Muscle Cell Migration in Moyamoya Disease"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-8656","authenticated-orcid":false,"given":"Shihao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3263-6797","authenticated-orcid":false,"given":"Yuanli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-9321","authenticated-orcid":false,"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"9476_CR1","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1161\/STR.0000000000000443","volume":"54","author":"NR Gonzalez","year":"2023","unstructured":"Gonzalez, N. R. et al. Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association\/American Stroke Association. Stroke 54, e465\u2013e479 (2023).","journal-title":"Stroke"},{"key":"9476_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the P, Treatment of Spontaneous Occlusion of the Circle of W, Health Labour Sciences Research Grant for Research on Measures for Infractable D","year":"2012","unstructured":"Research Committee on the P, Treatment of Spontaneous Occlusion of the Circle of W, Health Labour Sciences Research Grant for Research on Measures for Infractable D Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol. Med Chir. 52, 245\u2013266 (2012).","journal-title":"Neurol. Med Chir."},{"key":"9476_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda, S. & Houkin, K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 7, 1056\u20131066 (2008).","journal-title":"Lancet Neurol."},{"key":"9476_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/17474930241297031","volume":"20","author":"N Rifino","year":"2025","unstructured":"Rifino, N. et al. Diagnosis and management of adult Moyamoya angiopathy: An overview of guideline recommendations and identification of future research directions. Int J. Stroke 20, 512\u2013523 (2025).","journal-title":"Int J. Stroke"},{"key":"9476_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1440-1789.2004.00550.x","volume":"24","author":"Y Takekawa","year":"2004","unstructured":"Takekawa, Y., Umezawa, T., Ueno, Y., Sawada, T. & Kobayashi, M. Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology 24, 236\u2013242 (2004).","journal-title":"Neuropathology"},{"key":"9476_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.47.1","volume":"47","author":"Y Takagi","year":"2007","unstructured":"Takagi, Y., Kikuta, K., Nozaki, K. & Hashimoto, N. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol. Med Chir. 47, 1\u20134 (2007).","journal-title":"Neurol. Med Chir."},{"key":"9476_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2176\/nmc.oa.2016-0031","volume":"56","author":"Y Takagi","year":"2016","unstructured":"Takagi, Y. et al. Histopathological Characteristics of Distal Middle Cerebral Artery in Adult and Pediatric Patients with Moyamoya Disease. Neurol. Med Chir. 56, 345\u2013349 (2016).","journal-title":"Neurol. Med Chir."},{"key":"9476_CR8","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"F Ye","year":"2023","unstructured":"Ye, F. et al. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain 146, 4674\u20134689 (2023).","journal-title":"Brain"},{"key":"9476_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.120.032691","volume":"53","author":"V Roy","year":"2022","unstructured":"Roy, V. et al. Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function. Stroke 53, 1263\u20131275 (2022).","journal-title":"Stroke"},{"key":"9476_CR10","doi-asserted-by":"publisher","unstructured":"Morito D. et al. Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci. Rep. 4 https:\/\/doi.org\/10.1038\/srep04442 (2014).","DOI":"10.1038\/srep04442"},{"key":"9476_CR11","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu, W. et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6, e22542 (2011).","journal-title":"PLoS One"},{"key":"9476_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2014.01.011","volume":"1552","author":"S Sonobe","year":"2014","unstructured":"Sonobe, S. et al. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: A susceptibility gene for moyamoya disease. Brain Res. 1552, 64\u201371 (2014).","journal-title":"Brain Res."},{"key":"9476_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.721118","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. MMP-9 as a biomarker for predicting hemorrhagic strokes in Moyamoya Disease. Front. Neurol. 12, 721118 (2021).","journal-title":"Front. Neurol."},{"key":"9476_CR14","doi-asserted-by":"publisher","first-page":"e47158","DOI":"10.1371\/journal.pone.0047158","volume":"7","author":"YS Park","year":"2012","unstructured":"Park, Y. S. et al. The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One 7, e47158 (2012).","journal-title":"PLoS One"},{"key":"9476_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","volume":"13","author":"R Mertens","year":"2022","unstructured":"Mertens, R. et al. PJTsr. The genetic basis of Moyamoya Disease. Transl. Stroke Res. 13, 25\u201345 (2022).","journal-title":"Transl. Stroke Res."},{"key":"9476_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1156894","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu, H. et al. APOE as potential biomarkers of moyamoya disease. Front. Neurol. 14, 1156894 (2023).","journal-title":"Front. Neurol."},{"key":"9476_CR17","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/acn3.52076","volume":"11","author":"G Gorla","year":"2024","unstructured":"Gorla, G. et al. Angiopoietin-2 associates with poor prognosis in Moyamoya angiopathy. Ann. Clin. Transl. Neurol. 11, 1590\u20131603 (2024).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"9476_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00522-w","volume":"19","author":"D Guo","year":"2024","unstructured":"Guo, D., Dong, Y., Li, H., Li, H. & Yang, B. Proteomics and digital subtraction angiography approaches reveal CDH18 as a potential target for therapy of moyamoya disease. Biol. Direct 19, 76 (2024).","journal-title":"Biol. Direct"},{"key":"9476_CR19","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2021.6.FOCUS21284","volume":"51","author":"M Rallo","year":"2021","unstructured":"Rallo, M., Akel, O., Gurram, A. & Sun HJNf. Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review. Neurosurg. Focus 51, E5 (2021).","journal-title":"Neurosurg. Focus"},{"key":"9476_CR20","doi-asserted-by":"publisher","unstructured":"Vijay L. et al. Experimental animal models for the study of moyamoya disease. 51, https:\/\/doi.org\/10.3171\/2021.5.Focus21282 (2021).","DOI":"10.3171\/2021.5.Focus21282"},{"key":"9476_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3171\/2018.8.PEDS1883","volume":"23","author":"SA Choi","year":"2018","unstructured":"Choi, S. A. et al. Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model. J. Neurosurg. Pediatr. 23, 204\u2013213 (2018).","journal-title":"J. Neurosurg. Pediatr."},{"key":"9476_CR22","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2021.6.FOCUS21284","volume":"51","author":"MS Rallo","year":"2021","unstructured":"Rallo, M. S., Akel, O., Gurram, A. & Sun, H. Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review. Neurosurg. Focus 51, E5 (2021).","journal-title":"Neurosurg. Focus"},{"key":"9476_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2015.10.055","volume":"1630","author":"M Sato-Maeda","year":"2016","unstructured":"Sato-Maeda, M. et al. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease. Brain Res. 1630, 50\u201355 (2016).","journal-title":"Brain Res."},{"key":"9476_CR24","doi-asserted-by":"publisher","unstructured":"Morimoto T. et al. Dysregulation of RNF213 promotes cerebral hypoperfusion. Sci. Rep. 8, https:\/\/doi.org\/10.1038\/s41598-018-22064-8 (2018).","DOI":"10.1038\/s41598-018-22064-8"},{"key":"9476_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.brainres.2015.07.039","volume":"1624","author":"A Kanoke","year":"2015","unstructured":"Kanoke, A. et al. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease. Brain Res. 1624, 497\u2013505 (2015).","journal-title":"Brain Res."},{"key":"9476_CR26","unstructured":"Rao M. et al. Clinical and experimental pathology of Moyamoya disease. 116, 1845\u20131849 (2003)."},{"key":"9476_CR27","doi-asserted-by":"crossref","unstructured":"Yamada H. et al. The relationship between moyamoya disease and bacterial infection. Clin. Neurol. Neurosurg. S221\u2013S224 (1997).","DOI":"10.1016\/S0303-8467(97)00048-6"},{"key":"9476_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","volume":"19","author":"G Rossi","year":"2018","unstructured":"Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671\u2013687 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"9476_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00109-020-01990-z","volume":"99","author":"K Kretzschmar","year":"2021","unstructured":"Kretzschmar, K. Cancer research using organoid technology. J. Mol. Med. 99, 501\u2013515 (2021).","journal-title":"J. Mol. Med."},{"key":"9476_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373\u2013379 (2013).","journal-title":"Nature"},{"key":"9476_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature13863","volume":"516","author":"KW McCracken","year":"2014","unstructured":"McCracken, K. W. et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516, 400\u2013404 (2014).","journal-title":"Nature"},{"key":"9476_CR32","doi-asserted-by":"publisher","unstructured":"Reiner A. W. et al. Human blood vessel organoids as a model of diabetic vasculopathy. 565, https:\/\/doi.org\/10.1038\/s41586-018-0858-8 (2019).","DOI":"10.1038\/s41586-018-0858-8"},{"key":"9476_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2024.04.019","volume":"31","author":"L Dao","year":"2024","unstructured":"Dao, L. et al. Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids. Cell Stem Cell 31, 818\u2013833.e811 (2024).","journal-title":"Cell Stem Cell"},{"key":"9476_CR34","doi-asserted-by":"publisher","unstructured":"Ji Y. et al. Alzheimer\u2019s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery. Mol. Psychiatry. https:\/\/doi.org\/10.1038\/s41380-025-03041-w 2025.","DOI":"10.1038\/s41380-025-03041-w"},{"key":"9476_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115576","volume":"44","author":"M Arce","year":"2025","unstructured":"Arce, M. et al. KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Cell Rep. 44, 115576 (2025).","journal-title":"Cell Rep."},{"key":"9476_CR36","first-page":"525","volume":"50","author":"L Zhu","year":"2025","unstructured":"Zhu, L. et al. Construction of vascularized liver microtissues recapitulates angiocrine-mediated hepatocytes maturation and enhances therapeutic efficacy for acute liver failure. Bioact. Mater. 50, 525\u2013539 (2025).","journal-title":"Bioact. Mater."},{"key":"9476_CR37","doi-asserted-by":"crossref","unstructured":"JNm-c. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol. Med. Chir. 52, 245-266 (2012).","DOI":"10.2176\/nmc.52.245"},{"key":"9476_CR38","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1161\/STROKEAHA.123.044476","volume":"54","author":"S He","year":"2023","unstructured":"He, S. et al. Upregulated cytoskeletal proteins promote pathological Angiogenesis in Moyamoya disease. Stroke 54, 3153\u20133164 (2023).","journal-title":"Stroke"},{"key":"9476_CR39","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/s41596-019-0213-z","volume":"14","author":"RA Wimmer","year":"2019","unstructured":"Wimmer, R. A., Leopoldi, A., Aichinger, M., Kerjaschki, D. & Penninger, J. M. Generation of blood vessel organoids from human pluripotent stem cells. Nat. Protoc. 14, 3082\u20133100 (2019).","journal-title":"Nat. Protoc."},{"key":"9476_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/stem.1293","volume":"31","author":"K Okita","year":"2013","unstructured":"Okita, K. et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458\u2013466 (2013).","journal-title":"Stem Cells"},{"key":"9476_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2183\/pjab.85.348","volume":"85","author":"N Fusaki","year":"2009","unstructured":"Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 85, 348\u2013362 (2009).","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"key":"9476_CR42","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott, R. M. & Smith, E. R. Moyamoya disease and moyamoya syndrome. N. Engl. J. Med. 360, 1226\u20131237 (2009).","journal-title":"N. Engl. J. Med."},{"key":"9476_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.661578","volume":"12","author":"BM Fox","year":"2021","unstructured":"Fox, B. M., Dorschel, K. B., Lawton, M. T. & Wanebo, J. E. Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease. Front Neurol. 12, 661578 (2021).","journal-title":"Front Neurol."},{"key":"9476_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cellsig.2018.08.019","volume":"52","author":"A Frismantiene","year":"2018","unstructured":"Frismantiene, A., Philippova, M., Erne, P. & Resink, T. J. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity. Cell Signal 52, 48\u201364 (2018).","journal-title":"Cell Signal"},{"key":"9476_CR45","doi-asserted-by":"publisher","unstructured":"Gary K. O., Meena S. K., Brian R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, https:\/\/doi.org\/10.1152\/physrev.00041.2003 (2004).","DOI":"10.1152\/physrev.00041.2003"},{"key":"9476_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur, G. L., Jorgensen, H. F., Clarke, M. C. H., Bennett, M. R. & Mallat, Z. Vascular smooth muscle cells in atherosclerosis. Nat. Rev. Cardiol. 16, 727\u2013744 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"9476_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2016.04.051","volume":"1644","author":"J Wen","year":"2016","unstructured":"Wen, J. et al. Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish. Brain Res. 1644, 70\u201378 (2016).","journal-title":"Brain Res."},{"key":"9476_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep10178","volume":"5","author":"Z Starosolski","year":"2015","unstructured":"Starosolski, Z. et al. Ultra High-Resolution In vivo Computed Tomography Imaging of Mouse Cerebrovasculature Using a Long Circulating Blood Pool Contrast Agent. Sci. Rep. 5, 10178 (2015).","journal-title":"Sci. Rep."},{"key":"9476_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105339","volume":"154","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. Linking cortical astrocytic neogenin deficiency to the development of Moyamoya disease-like vasculopathy. Neurobiol. Dis. 154, 105339 (2021).","journal-title":"Neurobiol. Dis."},{"key":"9476_CR50","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/S0303-8467(97)00048-6","volume":"99","author":"H Yamada","year":"1997","unstructured":"Yamada, H. et al. The relationship between moyamoya disease and bacterial infection. Clin. Neurol. Neurosurg. 99, S221\u2013S224 (1997).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"9476_CR51","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim, J., Koo, B. K. & Knoblich, J. A. Human organoids: model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571\u2013584 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9476_CR52","volume":"5","author":"X Han","year":"2024","unstructured":"Han, X. et al. Landscape of human organoids: Ideal model in clinics and research. Innovations 5, 100620 (2024).","journal-title":"Innovations"},{"key":"9476_CR53","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13287-023-03521-2","volume":"14","author":"H Naderi-Meshkin","year":"2023","unstructured":"Naderi-Meshkin, H. et al. Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies. Stem Cell Res Ther. 14, 292 (2023).","journal-title":"Stem Cell Res Ther."},{"key":"9476_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1492","volume":"13","author":"S He","year":"2023","unstructured":"He, S. et al. Metabolomic signatures associated with pathological angiogenesis in moyamoya disease. Clin. Transl. Med. 13, e1492 (2023).","journal-title":"Clin. Transl. Med"},{"key":"9476_CR55","doi-asserted-by":"publisher","unstructured":"Binarova P., Tuszynski J. Tubulin: Structure, functions and roles in disease. Cells. 8, https:\/\/doi.org\/10.3390\/cells8101294 (2019).","DOI":"10.3390\/cells8101294"},{"key":"9476_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41580-020-0214-3","volume":"21","author":"C Janke","year":"2020","unstructured":"Janke, C. & Magiera, M. M. The tubulin code and its role in controlling microtubule properties and functions. Nat. Rev. Mol. Cell Biol. 21, 307\u2013326 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9476_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ceb.2019.03.017","volume":"60","author":"JJ Vicente","year":"2019","unstructured":"Vicente, J. J. & Wordeman, L. The quantification and regulation of microtubule dynamics in the mitotic spindle. Curr. Opin. Cell Biol. 60, 36\u201343 (2019).","journal-title":"Curr. Opin. Cell Biol."},{"key":"9476_CR58","doi-asserted-by":"publisher","unstructured":"Guedes-Dias P., Holzbaur E. L. F. Axonal transport: Driving synaptic function. Science. 366, https:\/\/doi.org\/10.1126\/science.aaw9997 (2019).","DOI":"10.1126\/science.aaw9997"},{"key":"9476_CR59","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ajpath.2010.10.001","volume":"178","author":"R Silverman-Gavrila","year":"2011","unstructured":"Silverman-Gavrila, R. et al. MJTAjop. Rear polarization of the microtubule-organizing center in neointimal smooth muscle cells depends on PKC\u03b1, ARPC5, and RHAMM. Am. J. Pathol. 178, 895\u2013910 (2011).","journal-title":"Am. J. Pathol."},{"key":"9476_CR60","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/cm.21302","volume":"73","author":"X Zhu","year":"2016","unstructured":"Zhu, X., Efimova, N., Arnette, C., Hanks, S. & Kaverina, I. J. C. Podosome dynamics and location in vascular smooth muscle cells require CLASP-dependent microtubule bending. Cytoskeleton 73, 300\u2013315 (2016).","journal-title":"Cytoskeleton"},{"key":"9476_CR61","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/156800907781662266","volume":"7","author":"E Pasquier","year":"2007","unstructured":"Pasquier, E., Andr\u00e9, N. & Braguer DJCcdt. Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment. Curr. Cancer Drug Targets 7, 566\u2013581 (2007).","journal-title":"Curr. Cancer Drug Targets"},{"key":"9476_CR62","first-page":"93","volume":"28","author":"A Th\u00e9venin","year":"2013","unstructured":"Th\u00e9venin, A. et al. Proteins and mechanisms regulating gap-junction assembly, internalization, and degradation. Hysiology 28, 93\u2013116 (2013).","journal-title":"Hysiology"},{"key":"9476_CR63","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/ijms19061663","volume":"19","author":"F Molica","year":"2018","unstructured":"Molica, F., Figueroa, X., Kwak, B., Isakson, B. & Gibbins, J. Connexins and Pannexins in Vascular Function and Disease. Int. J. Mol. Sci. 19, 1663 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"9476_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbamem.2017.05.018","volume":"1860","author":"I Epifantseva","year":"2018","unstructured":"Epifantseva, I. & Shaw, R. M. Intracellular trafficking pathways of Cx43 gap junction channels. Biochim. Biophys. Acta (BBA) - Biomembranes. 1860, 40\u201347 (2018).","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembranes."},{"key":"9476_CR65","doi-asserted-by":"publisher","first-page":"7580","DOI":"10.1523\/JNEUROSCI.0187-17.2017","volume":"37","author":"E Ivanova","year":"2017","unstructured":"Ivanova, E., Kovacs-Oller, T. & Sagdullaev, B. T. Vascular Pericyte Impairment and Connexin43 Gap Junction Deficit Contribute to Vasomotor Decline in Diabetic Retinopathy.  J. Neurosci. 37, 7580\u20137594 (2017).","journal-title":"J. Neurosci."},{"key":"9476_CR66","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.026","volume":"27","author":"J Liao","year":"2018","unstructured":"Liao, J. et al. Expression of Connexin43 in Cerebral Arteries of Patients with Moyamoya Disease. J. Stroke Cerebrovasc. Dis. 27, 1107\u20131114 (2018).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"9476_CR67","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1161\/ATVBAHA.121.316600","volume":"41","author":"C Yap","year":"2021","unstructured":"Yap, C., Mieremet, A., de Vries, C., Micha, D. & de Waard, V. J. A. thrombosis, biology v. Six Shades of Vascular Smooth Muscle Cells Illuminated by KLF4 (Kr\u00fcppel-Like Factor 4). Arterioscler. Thromb. Vasc. Biol. 41, 2693\u20132707 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"9476_CR68","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/iub.298","volume":"62","author":"B Zheng","year":"2010","unstructured":"Zheng, B., Han, M. & Wen, J. K. Role of Kr\u00fcppel-like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells. IUBMB Life 62, 132\u2013139 (2010).","journal-title":"IUBMB Life"},{"key":"9476_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0423-7","volume":"14","author":"A Kronenburg","year":"2014","unstructured":"Kronenburg, A., Braun, K. P., van der Zwan, A. & Klijn, C. J. Recent advances in moyamoya disease: pathophysiology and treatment. Curr. Neurol. Neurosci. Rep. 14, 423 (2014).","journal-title":"Curr. Neurol. Neurosci. Rep."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09476-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09476-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09476-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:06:33Z","timestamp":1770642393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09476-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9476"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09476-9","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"198"}}